<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>medsurfnews.com</title><link>http://www.medsurfnews.com</link><description>Le ultime risorse da Medsurfnews.com</description><language>it</language><pubDate></pubDate><copyright>Healthware.it</copyright><webmaster>francesco.raimondo@healthware.it</webmaster><image><title>Medsurfnews Rss</title><url>http://www.medsurfnews.com/images/logo.jpg</url><link>http://www.medsurfnews.com</link></image>
	
	
	
<item>
<category>Ematologia</category>
<title>Home Monitoring of INR</title>
<link>http://www.medsurfnews.com/contents/it/7118/display/home-monitoring-of-inr.aspx</link>
<description><![CDATA[The greatest problem in warfarin use is given by the need to monitor coagulation status with a certain frequency, so in the USA the possibility to control INR at home has been recently introduced. But is this practice safe, easily feasible and fit for all patients? In order to answer this question, self-control has been compared with traditional control on 2922 patients belonging to the Veterans Affairs Medical Centers, under warfarin therapy for valvular diseases or atrial fibrillation. ]]></description>
<pubDate>Mon, 12 Mar 2012 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Haemophilia gene therapy shows early success</title>
<link>http://www.medsurfnews.com/contents/it/6926/display/haemophilia-gene-therapy-shows-early-success.aspx</link>
<description><![CDATA[Six patients were given a virus that infects the body with the blueprints needed to produce blood-clotting proteins. Four of them could then stop taking their drugs. Just one injection appears to be enough to mean people with haemophilia B no longer need medication, according to an early study in the UK and the US.

]]></description>
<pubDate>Tue, 13 Dec 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Hydroxyurea does not cause genetic damage in children with sickle cell anemia</title>
<link>http://www.medsurfnews.com/contents/it/6927/display/hydroxyurea-does-not-cause-genetic-damage-in-children-with-sickle-cell-anemia.aspx</link>
<description><![CDATA[Young infants and toddlers with sickle cell anemia who received the drug hydroxyurea were no more likely to have cellular genetic damage than those who received a placebo or inactive medicine. Hydroxyurea was approved by the U.S. Food and Drug Administration as a treatment for adults with sickle cell disease in 1998, but it has not yet been approved for use in children. Hydroxyurea reduces the amount of sickle hemoglobin by stimulating the production of fetal hemoglobin, which results in healthier red blood cells and a reduction in the frequency and severity of the complications associated with the disorder.]]></description>
<pubDate>Tue, 13 Dec 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>FDA approves deferiprone to treat patients with excess iron in the body</title>
<link>http://www.medsurfnews.com/contents/it/6790/display/fda-approves-deferiprone-to-treat-patients-with-excess-iron-in-the-body.aspx</link>
<description><![CDATA[The U.S. Food and Drug Administration today approved deferiprone to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.
]]></description>
<pubDate>Wed, 19 Oct 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Tranexamic Acid after Severe Injuries</title>
<link>http://www.medsurfnews.com/contents/it/6609/display/tranexamic-acid-after-severe-injuries.aspx</link>
<description><![CDATA[The use of tranexamic acid during surgeries is associated with less blood losses and less needs of transfusions. According to this statement, with a randomized trial, partly sponsored by pharmaceutical industry (CRASH-2: Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) the efficacy of this antifibrinolytic has been assessed in 20,211 patients experimenting injuries and bleeding risk. The drug (or placebo) has been given within the first 8 hours after injury; the dose of tranexamic acid has been 1 g within the first 10 minutes, followed by a slow infusion of 1 g during the following 8 hours. ]]></description>
<pubDate>Mon, 25 Jul 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Improved survival and treatment for chronic blood disorders</title>
<link>http://www.medsurfnews.com/contents/it/6453/display/improved-survival-and-treatment-for-chronic-blood-disorders.aspx</link>
<description><![CDATA[New research from Karolinska Institutet shows that hydroxyurea, one type of cytotoxic treatment for chronic myeloproliferative blood disorders, does not increase the risk of developing acute leukaemia, as had previously been suspected. Rather, it is the disease itself that mainly increases this risk. Another new study by the same group of researchers shows that mortality from chronic myeloid leukaemia has decreased sharply since the approval of the drug Imatinib as a standard treatment in 2001.
]]></description>
<pubDate>Tue, 17 May 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Gene Therapy Corrected Rare Bleeding Disorder</title>
<link>http://www.medsurfnews.com/contents/it/6071/display/gene-therapy-corrected-rare-bleeding-disorder.aspx</link>
<description><![CDATA[But one of 10 boys developed leukemia, possibly from treatment, researchers say.]]></description>
<pubDate>Mon, 6 Dec 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Antiplatelet Drugs, Anticoagulants and Hemorrhagic Risk</title>
<link>http://www.medsurfnews.com/contents/it/5936/display/antiplatelet-drugs-anticoagulants-and-hemorrhagic-risk.aspx</link>
<description><![CDATA[After a myocardial infarction, the use of aspirin and clopidogrel is recommended, but many patients in this conditions also need a vitamin-K antagonist. But these drugs together cause an increase in hemorrhagic risk, even severe, and they consequently increase overall morbidity and mortality. In order to verify the safety of a contemporary use of anticoagulation and antiplatelet drugs, then, some researchers in Denmark have identified 40,000 adults in the national registry, with the prescription of one or more of the following drugs: aspirin, clopidogrel, warfarin in the 90 days following myocardial infarction. ]]></description>
<pubDate>Wed, 27 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>New Real-Time Blood Monitoring May Lessen the Need for Transfusions During Surgery</title>
<link>http://www.medsurfnews.com/contents/it/5913/display/new-real-time-blood-monitoring-may-lessen-the-need-for-transfusions-during-surgery.aspx</link>
<description><![CDATA[An advance that tracks a patient's hemoglobin levels without drawing blood could drastically cut down the need for extra blood in the operating room.]]></description>
<pubDate>Mon, 25 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Ematologia</category>
<title>Screening of Helicobacter pylori Infection After Gastrectomy for Cancer or Peptic Ulcer: Results of a Cohort Study</title>
<link>http://www.medsurfnews.com/contents/it/5925/display/screening-of-helicobacter-pylori-infection-after-gastrectomy-for-cancer-or-peptic-ulcer-results-of-a-cohort-study.aspx</link>
<description><![CDATA[Early transfusion of FFP is associated with an increased risk of postinjury MOF, even after adjusting for age, ISS, and PRBC transfusion. Caution is warranted in developing protocols for empirical FFP transfusion. Specifically, transfusion triggers for FFP should be reexamined, as well as the practice of delivering FFP in fixed ratios to the units of PRBCs transfused.]]></description>
<pubDate>Mon, 25 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	</channel></rss>
	



